All episodes
UNITE Randomized Clinical Trial
Advancements in Neurology: A Conversation with Dr. Walter Koroshetz - Part 2
Advancements in Neurology: A Conversation with Dr. Walter Koroshetz - Part 1
Women History Minute - Ellen Grass
Shedding a Light on Neurodiversity
Dihydroergotamine Nasal Powder
Updates on All Things Myositis – Part 2
Updates on All Things Myositis – Part 1
September 2025 President Spotlight: AAN Brain Health Summit
August 2025 Capitol Hill Report: Neurology off the Hill
Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years - Part 2
GLP-1RA–Associated Diabetic Lumbosacral Radiculoplexus and Common Fibular Neuropathies
Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years - Part 1
Foundational Neurology Series - Part 5
Foundational Neurology Series - Part 4
Foundational Neurology Series - Part 3
FDG-PET-Based Machine Learning Framework to Support Neurologic Decision-Making
Optimal Timing of Anticoagulation After Ischemic Stroke and Atrial Fibrillation
Efficacy and Safety of Symbravo® in Participants with Migraine Experiencing an Inadequate Response to Oral CGRP Inhibitors
Foundational Neurology Series - Part 2
Foundational Neurology Series - Part 1
Implications for Diagnostic Criteria for Primary Lateral Sclerosis
Long-Term Fatigue Following Transient Ischemic Attack
Updates in Neuroinfectious Diseases - Part 10
Updates in Neuroinfectious Diseases - Part 9
Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and APOE Genotype in Alzheimer Disease - Part 2
Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and APOE Genotype in Alzheimer Disease - Part 1
The Effect of Epilepsy Surgery on Tonic–Clonic Seizures
Women History Minute - Tilly Edinger
August 2025 President Spotlight: Strategizing to reach the AAN's goals
July 2025 Capitol Hill Report: Medicare Physician Fee Schedule
Medical Student Perspectives on Stigma in FND
Medical Student Perspectives on Stigma in FND
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Updates in Neuroinfectious Diseases - Part 8
Updates in Neuroinfectious Diseases - Part 7
Updates in Neuroinfectious Diseases - Part 6
Clinical Approach to Dementia Risk in Patients with Parkinson Disease
Embolic Stroke of Undetermined Source Treated With Antiplatelet Agents or Anticoagulation
Updates in Neuroinfectious Diseases - Part 5
Efficacy of Aerobic Exercise and Coaching on Physical Fitness in Neuromuscular Disease - Part 2
July 2025 Capitol Hill Report: Reconciliation Bill
Diagnostic Performance of Plasma Biomarkers in the Outpatient Memory Clinic
Efficacy of Aerobic Exercise and Coaching on Physical Fitness in Neuromuscular Disease - Part 1
Updates in Neuroinfectious Diseases - Part 4
Updates in Neuroinfectious Diseases - Part 3
hES Cell-Derived Dopaminergic Neurons for Parkinson Disease - Part 2
hES Cell-Derived Dopaminergic Neurons for Parkinson Disease - Part 1
Neurology Residency Training in 2022
Updates in Neuroinfectious Diseases - Part 2
Updates in Neuroinfectious Diseases - Part 1
July 2025 President Spotlight: The Role Science Plays
Prehospital Large-Vessel Occlusion Stroke Detection Scales
Women History Minute - Mary Lasker
2025 European Stroke Organization Conference Highlights - Part 3
2025 European Stroke Organization Conference Highlights - Part 2
2025 European Stroke Organization Conference Highlights - Part 1
Role of Central Sensitization Syndrome in Patients With Autonomic Symptoms
Women History Minute - Jean Holowach-Thurston
Acute Symptomatic Seizures During CAR T-Cell Therapy for Hematologic Malignancies - Part 2
June 2025 President Spotlight: Advocacy in Neurology
Acute Symptomatic Seizures During CAR T-Cell Therapy for Hematologic Malignancies - Part 1
Electronic Medical Record Alert to Prevent Iatrogenic Interventions in Patients With PNES
June 2025 Capitol Hill Report
Inebilizumab in Generalized Myasthenia Gravis
Optic Nerve Imaging - Part 3
Patient Perspectives on Antiseizure Medication Discontinuation
Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge
Biopsy-Confirmed Small Vessel Primary CNS Vasculitis - Part 3
Biopsy-Confirmed Small Vessel Primary CNS Vasculitis - Part 2
Seizure Action Plans in Pediatric Convulsive Status Epilepticus - Part 2
Seizure Action Plans in Pediatric Convulsive Status Epilepticus - Part 1
Clinical Reasoning Series: Intracerebral Hemorrhage and Tortuous Retinal Arterioles
Functional Seizures and Driving - Part 3
Functional Seizures and Driving - Part 2
Functional Seizures and Driving - Part 1
Biopsy-Confirmed Small Vessel Primary CNS Vasculitis - Part 1
Clinical Criteria for LATE
Optic Nerve Imaging - Part 2
Introduction to the New AAN President, Natalia S. Rost, MD, MPH, FAAN, FAHA
False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice - Part 2
False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice - Part 1
Transforming Neurology Education: Evaluating Teaching Incentive Programs
Optic Nerve Imaging - Part 1
Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 2
AAN's President's Award Recipient for 2025 - Part 2
Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 1
AAN's President's Award Recipient for 2025 - Part 1
Progressive Multiple Sclerosis
Neuroimmunology Update 2025: Autoimmune Encephalitis Outcomes
Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 2
Spontaneous Intracranial Hypotension Updates
Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 1
Neuroimmunology Update 2025: MOGAD Treatments
Neuroimmunology Update 2025: Autoimmune Encephalitis Outcomes
The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting
Diagnosis of Alzheimer Disease Using Plasma Biomarkers
Women With Genetic Epilepsies
Neuroimmunology Update 2025: AQP4+ NMOSD Treatment Landscape
BTK Inhibitors in Multiple Sclerosis Treatment - Part 3